MorphoSys AG ADR buy Stakeholder
Start price
05.08.20
/
50%
€29.00
Target price
04.11.21
-
Performance (%)
-62.07%
End price
17.08.21
€11.00
Summary
This prediction ended on 17.08.21 with a price of €11.00. Massive losses of -62.07% were the result for the BUY prediction by Stakeholder. Stakeholder has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
MorphoSys AG ADR | - | - | - | - |
iShares Core DAX® | 2.831% | 1.236% | 14.788% | 17.647% |
iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% | 50.762% |
iShares Nikkei 225® | 2.007% | -2.135% | 19.861% | 4.937% |
iShares S&P 500 | 2.257% | 0.451% | 30.090% | 43.940% |
Comments by Stakeholder for this prediction
In the thread Morphosys AG diskutieren
Zulassung des Krebsmedikamentes Monjuvi in den USA